Back to overview
July 29, 2015
Testimonial

“Un entrepreneuriat multidimensionnel exige des solutions d’assurance durables”

Materialise CEO e1440746634179

Depuis 25 ans, Materialise développe des applications innovantes pour le secteur médical et industriel. Aujourd’hui, l’entreprise technologique de Louvain est leader du marché de l’impression 3D, avec plus de 900 employés et un chiffre d’affaires de 63 millions d’euros.

Dans le secteur médical, la réputation de Materialise est déjà bien établie. L’entreprise a fait la une de l’actualité en assistant les chirurgiens qui ont réalisé la première greffe de visage en Belgique. Pour l’opération, Materialise a mis au point une planification chirurgicale 3D et des instruments spécifiques au patient.

« Je ne gère pas mon entreprise pour optimiser mon patrimoine, mais pour rendre le monde meilleur grâce à nos produits », déclare le CEO, Fried Vancraen. « Une société ne peut entreprendre de façon multidimensionnelle que si elle peut compter sur des solutions d’assurance durables. »

Vanbreda Risk & Benefits a répertorié les risques de Materialise et conçu un package d’assurances (hospitalisation, accidents du travail, pension et auto) pour les collaborateurs de l’entreprise actifs dans le monde entier.

Materialise

Related posts

JLPSF13142

How your organisation can boost mental resilience

People
27.02.2026

At the coffee machine or at birthday parties, we often discuss the downsides of our jobs: high workloads, looming burnouts, rising absenteeism. According to Prof. Nele Jacobs, a mental health expert and the CEO of Faresa, we are selling ourselves short by doing so. Her message is clear: work is essentially a healthy activity and can become a significant source of mental resilience, provided that organisations create the right conditions.

Read more
Read more about How your organisation can boost mental resilience
JLPSF28959

Increase in co-payment for medicines: what does this mean for the insurance plans of employers and their employees?

People
16.12.2025

Starting in 2026, the federal government will introduce a minimum co-payment of €2 for all medicines you buy at the pharmacy. The General Council of the RIZIV describes the purpose of this measure as follows: ‘This is a solidarity contribution that will be used to reinvest in better social security protection for patients.’ But what does this mean in practice for the medical plans you provide, as an employer for your employees?

Read more
Read more about Increase in co-payment for medicines: what does this mean for the insurance plans of employers and their employees?
U7353792727 photorealistic image bright and airy modern office b88a0a87 c730

From pension statement to pension overview: what will change in 2026?

People
14.12.2025

Starting in 2026, a significant change will occur in communication regarding supplementary pensions: the familiar pension statement will disappear and be replaced by the pension overview. This change is an implementation of the Transparency Act, with a view to imposing uniform rules on all pension institutions about communication with members in order to ensure greater clarity. In the downloadable note below, we explain everything in detail.

Read more
Read more about From pension statement to pension overview: what will change in 2026?
Search